Atrás
Precio Psyence Biomedical Ltd (PBM)
Gráfico del Precio de Acciones PBM
PBM Dividendos
Psyence Biomedical Ltd
$0.67
-0.01%
$0
Al cierre: Jan 16, 16:00:00 GMT-5
$0.68
1.62%
$0.01
Mercado Posterior: Jan 16, 20:00:00 GMT-5
Estadísticas clave
Cierre Anterior
$0.6701
Precio de apertura
$0.6882
Rango del día
$0.6167 - $0.69
Rango de 52 semanas
$0.662 - $17.93
Volumen
506.8K
Volumen promedio
1.3M
EPS (TTM)
41.27
Rendimiento de dividendos
--
Cap. de mercado
$1.2M
¿Qué es PBM?
Psyence Biomedical Ltd. is a holding company, which engages in the development and commercialization of pharmaceutical products in neurology. The company is headquartered in Toronto, Ontario and currently employs 12 full-time employees. The company went IPO on 2021-12-10. The firm is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. The company is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.
Características
Estrategias de Trading
© 2025 Finture Development Limited. All rights reserved
